FindTrial
Sign In

Clinical observation on bacteroides fragilis (BF839) reducing bone marrow suppression after chemotherapy in patients with breast cancer

Clinical observation on bacteroides fragilis (BF839) reducing bone marrow suppression after chemotherapy in patients with breast cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100054876
Enrollment
Unknown
Registered
2021-12-28
Start date
2019-12-01
Completion date
Unknown
Last updated
2022-12-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer

Interventions

Intervention group:Bacteroides fragilis (BF839)
Control group:No

Sponsors

The Second Affiliated Hospital of Guangzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Aged >= 20 and 3 months. 4. Patients and family members can receive follow-up visits and follow-up inspections on time.

Exclusion criteria

Exclusion criteria: 1. Received other clinical trials or new dementia drug treatments within one month. 2. Inability to eat on their own. 3. Patients suffering from tumors, severe heart, liver, and kidney insufficiency, and critically ill diseases. 4. Have obvious protein food allergies.

Design outcomes

Primary

MeasureTime frame
Blood routine;—

Countries

China

Contacts

Public ContactZhang Lehong

The Second Affiliated Hospital of Guangzhou Medical University?

328598897@qq.com+86 20 34152396

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026